|
Federal
Register Notices > Notices of
Registration - 2000 > Radian International LLC
[Federal Register: September 6, 2000 (Volume 65,
Number 173)]
[Notices]
[Page 54070-54071]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06se00-100]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice
of Registration
By Notice dated May 11, 2000, and published in the
Federal Register On May 23, 2000, (65 FR 33354), Radian International
LLC, 14050 Summit Drive #121, P.O. Box 201088, Austin, Texas 78720-1088,
made application by renewal to the Drug Enforcement Administration (DEA)
to be registered as a bulk manufacturer of the basic classes of
controlled substances listed below:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
| N,N-Dimethylamphetamine (1480) |
I |
| Aminorex (1585) |
I |
| 4-Methylaminorex (cis isomer)
(1590) |
I |
| Methaqualone (2565) |
I |
| Alpha-Ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide
(7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Mescaline (7381) |
I |
| 3,4,5-Trimethoxyamphetamine
(7390) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine
(7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine
(7392) |
I |
| 4-Methy1-2,5-dimethoxyamphetamine
(7395) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,
5-Dimethoxy-4-ethylamphetamine (7399) |
I |
| 3, 4-Methylenedioxyamphetamine
(7400) |
I |
| 5-Methoxy-3,4-methylenedioxyamphetamine
(7401) |
I |
| N-Hydroxy-3,4-methylenedioxyamphetamine
(7402) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine
(7404) |
I |
| 3,4-Methylenedioxymetham-phetamine
(7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| Bufotenine (7433) |
I |
| Diethyltryptamine (7434) |
I |
| Dimethyltryptamine (7435) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| Acetyldihydrocodeine (9051) |
I |
| Benzylmorphine (9052) |
I |
| Codeine-N-oxide (9053 |
I |
| Dihydromorphine (9145) |
I |
| Heroin (9200) |
I |
| Morphine-N-oxide (9307) |
I |
| Normorphine (9313) |
I |
| Pholcodine (9314) |
I |
| Acetylmethadol (9601) |
I |
| Allyprodine (9602) |
I |
| Alphacetylmethadol except |
|
| Levo-Alphacetylmethadol (9603) |
I |
| Alphameprodine (9604) |
I |
| Alphamethadol (9605) |
I |
| Betacetylmethadol (9607) |
I |
| Betameprodine (9608) |
I |
| Betamethadol (9609) |
I |
| Betaprodine (9611) |
I |
| Hydromorphinol (9627) |
I |
| Noracymethadol (9633) |
I |
| Norlevorphanol (9634) |
I |
| Normethadone (9635) |
I |
| Trimeperidine (9646) |
I |
| Para-Flurofentanyl (9812) |
I |
| 3-Methylfentanyl (9813) |
I |
| Alpha-methylfentanyl (9814) |
I |
| Acetyl-alpha-methylfentanyl
(9815) |
I |
| Beta-hydroxyfentanyl (9830) |
I |
| Beta-hydroxy-3-methylfentanyl
(9831) |
I |
| Alpha-Methylthiofentanyl (9832) |
I |
| 3-Methylthiofentanyl (9833) |
I |
| Thiofentanyl (9835) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Phenmetrazine (1631) |
II |
| Methylphenidate (1724) |
II |
| Amobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| Glutethimide (2550) |
II |
| Nabilone (7379) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| 1-Piperidinocyclohexanecar-bonitrile
(8603) |
II |
| Alphaprodine (9010) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Diphenoxylate (9170) |
II |
| Benzoylecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Levomethorphan (9210) |
II |
| Levorphanol (9220) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Methadone-intermediate (9254) |
II |
| Morphine (9300) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
The firm plans to manufacture small quantities of
the listed controlled substances to make deuterated and non-deuterated
drug reference standards which will be distributed to analytical and
forensic laboratories for drug testing programs.
DEA has considered the factors in Title 21, United
States Code, Section 823(a)
and determined that the registration of Radian International LLC to
manufacture the listed controlled substances is consistent with the
public interest at this time. DEA has investigated Radian International
LLC on a regular basis to ensure that the company's continued
registration is consistent with the public interest. These
investigations have included inspection and testing of the company's
physical security systems, audits of the company's records, verification
of the company's compliance with state and local laws, and a review of
the company's background and history. Therefore, pursuant to 21
U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant
Administrator, Office of Diversion Control, hereby orders that the
application submitted by the above firm for registration as a
bulk
[[Page 54071]]
manufacturer of the basic classes of controlled
substances listed above is granted.
August 21, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 00-22688 Filed 9-05-00; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
